Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6XXV

Crystal Structure of a computationally designed Immunogen S2_1.2 in complex with its elicited antibody C57

Summary for 6XXV
Entry DOI10.2210/pdb6xxv/pdb
Related6S3D 6XWI
DescriptorAntibody C57, Heavy Chain, Antibody C57, Light Chain, S2_1.2, ... (4 entities in total)
Functional Keywordsepitope scaffold, de novo designed protein, immunogen, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains6
Total formula weight134010.13
Authors
Yang, C.,Sesterhenn, F.,Correia, B.E.,Pojer, F. (deposition date: 2020-01-28, release date: 2020-04-22, Last modification date: 2024-10-23)
Primary citationSesterhenn, F.,Yang, C.,Bonet, J.,Cramer, J.T.,Wen, X.,Wang, Y.,Chiang, C.I.,Abriata, L.A.,Kucharska, I.,Castoro, G.,Vollers, S.S.,Galloux, M.,Dheilly, E.,Rosset, S.,Corthesy, P.,Georgeon, S.,Villard, M.,Richard, C.A.,Descamps, D.,Delgado, T.,Oricchio, E.,Rameix-Welti, M.A.,Mas, V.,Ervin, S.,Eleouet, J.F.,Riffault, S.,Bates, J.T.,Julien, J.P.,Li, Y.,Jardetzky, T.,Krey, T.,Correia, B.E.
De novo protein design enables the precise induction of RSV-neutralizing antibodies.
Science, 368:-, 2020
Cited by
PubMed Abstract: De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.
PubMed: 32409444
DOI: 10.1126/science.aay5051
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.20116418766 Å)
Structure validation

226707

건을2024-10-30부터공개중

PDB statisticsPDBj update infoContact PDBjnumon